SCHEMBL5586919

SCHEMBL5586919

CCCCOc1c(O)c(O)cc(CCC)c1CCC

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 2/20 0.41
ALOX5 P09917 5/20 0.40
HMGCR P04035 1/20 0.38
NPC1 O15118 1/20 0.36
HPGD P15428 1/20 0.36
MAPK1 P28482 1/20 0.36
HTT P42858 1/20 0.36
RAB9A P51151 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
AKR1C4 P17516 1/20 0.36
AKR1C3 P42330 1/20 0.36
AKR1C2 P52895 1/20 0.36
AKR1C1 Q04828 1/20 0.36
THRA P10827 1/20 0.35
THRB P10828 1/20 0.35
PTPN1 P18031 1/20 0.35
LTB4R Q15722 1/20 0.34
LTA4H P09960 1/20 0.34
TYR P14679 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5588101 0.94 ALOX5 (0.44) ESR1ALOX5AKR1C4AKR1C3AKR1C2
SCHEMBL5589009 0.90 ALOX5 (0.43) ESR1ALOX5NPC1HPGDMAPK1
SCHEMBL5589659 0.89 ALOX5 (0.49) ESR1ALOX5NPC1HPGDMAPK1
SCHEMBL5587443 0.88 ALOX5 (0.51) ESR1ALOX5HTTAKR1C4AKR1C3
SCHEMBL5588481 0.88 ALOX5 (0.51) ESR1ALOX5HTTAKR1C4AKR1C3
SCHEMBL5587748 0.88 ALOX5 (0.51) ESR1ALOX5HTTAKR1C4AKR1C3
SCHEMBL5589500 0.88 ALOX5 (0.51) ESR1ALOX5HTTAKR1C4AKR1C3
SCHEMBL5590133 0.88 ALOX5 (0.51) ESR1ALOX5HTTAKR1C4AKR1C3
SCHEMBL5588320 0.84 ALOX5 (0.51) ESR1ALOX5HTTAKR1C4AKR1C3
SCHEMBL5588897 0.84 ALOX5 (0.51) ESR1ALOX5HTTAKR1C4AKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 ESR1 1108/4885ALOX5 188/4885HMGCR 3000/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.